Target Gene/Pathway Pathway / Gene
Search results
Showing 1 to 10 of 74 entries
No. | KEGG GENES | KEGG PATHWAY | KEGG DRUG | DrugBank | 指定難病告示番号 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 |
SIGMAR1
💬1. SIGMAR1
| 2件: Amyotrophic lateral sclerosis Amyotrophic lateral sclerosis, Pathways of neurodegeneration - multiple diseases | Dextromethorphan
Dextromethorphan
💬1. SIGMAR1
| Dextromethorphan | 11件: 2 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156 💬1. SIGMAR1
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
2 |
ADORA1
💬2. ADORA1
| 7件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, cAMP signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Morphine addiction 7件: cGMP-PKG signaling pathway, cAMP signaling pathway, Sphingolipid signaling pathway, Neuroactive ... | Caffeine
Caffeine
💬2. ADORA1
| Caffeine | 8件: 2 2, 6, 21, 46, 78, 96, 97, 265 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
3 |
ADORA1
💬3. ADORA1
| 7件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, cAMP signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Morphine addiction 7件: cGMP-PKG signaling pathway, cAMP signaling pathway, Sphingolipid signaling pathway, Neuroactive ... | Caffeine hydrate
Caffeine hydrate
💬3. ADORA1
| Caffeine | 8件: 2 2, 6, 21, 46, 78, 96, 97, 265 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
4 |
ADORA2A
💬4. ADORA2A
| 7件: Rap1 signaling pathway Rap1 signaling pathway, Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Parkinson disease, Alcoholism 7件: Rap1 signaling pathway, Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-re ... | Caffeine
Caffeine
💬4. ADORA2A
| Caffeine | 8件: 2 2, 6, 21, 46, 78, 96, 97, 265 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
5 |
ADORA2A
💬5. ADORA2A
| 7件: Rap1 signaling pathway Rap1 signaling pathway, Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Parkinson disease, Alcoholism 7件: Rap1 signaling pathway, Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-re ... | Caffeine hydrate
Caffeine hydrate
💬5. ADORA2A
| Caffeine | 8件: 2 2, 6, 21, 46, 78, 96, 97, 265 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
6 |
ADRA2A
💬6. ADRA2A
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Dexmedetomidine
Dexmedetomidine
💬6. ADRA2A
| Dexmedetomidine | 14件: 2 2, 4, 6, 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬6. ADRA2A
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
7 |
ADRA2B
💬7. ADRA2B
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Dexmedetomidine
Dexmedetomidine
💬7. ADRA2B
| Dexmedetomidine | 14件: 2 2, 4, 6, 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬7. ADRA2B
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
8 |
ADRA2C
💬8. ADRA2C
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Dexmedetomidine
Dexmedetomidine
💬8. ADRA2C
| Dexmedetomidine | 14件: 2 2, 4, 6, 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬8. ADRA2C
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
9 |
DRD2
💬9. DRD2
| 8件: Rap1 signaling pathway Rap1 signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Dopaminergic synapse, Parkinson disease, Cocaine addiction, Alcoholism 8件: Rap1 signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Gap jun ... | Cariprazine
Cariprazine
💬9. DRD2
| Cariprazine | 1件: 21 21 💬9. DRD2
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
10 |
GABRA1
💬10. GABRA1
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction 6件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse ... | Propofol
Propofol
💬10. GABRA1
| Propofol | 9件: 6 6, 21, 22, 34, 46, 70, 75, 98, 296 💬
|